Royal Philips has announced an expansion of its ultrasound portfolio with new imaging tools and features for cardiology, designed to “increase diagnostic confidence and workflow efficiency”. Philips will be showcasing these developments through its participation in the EuroEcho 2021 Virtual Congress (9–11 December, virtual).
The latest release includes updates to the EPIQ CVx and Affiniti CVx ultrasound platforms, automated analysis, Collaboration Live remote diagnosis and Cardiovascular Workspace—IntelliSpace Cardiovascular—end-to-end workflow
“With echocardiography the first imaging modality utilised for a greater volume of patients, clinicians are relying on ultrasound to provide care more than ever before,” said Jeff Cohen, general manager of Ultrasound at Philips. “Cardiac imaging workflows need to be streamlined at every step to address the volume and complexity of cases. Philips echocardiography provides a connected ecosystem of integrated workflow solutions for cardiology.
“Combined with advanced diagnostic tools, our integrated solutions deliver clear insights on the patient’s condition quickly. These recent introductions also reinforce how our ultrasound capabilities bring strong clinical value to areas outside of echocardiography, including liver disease management, to help improve decision support and care at each step in the patient journey.”
“Imaging performance is the most important attribute to allow me to be confident in my diagnosis and treatment planning,” said Roberto Lang, director, Noninvasive Cardiac Imaging Laboratory, University of Chicago, Chicago, USA.
